Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: kmwittkowski

October 4, 2022 Food / Non-pharma applications

The effect of alpha-cyclodextrin on post-prandial glucose excursions, a systematic meta analysis

Alpha-cyclodextrin (αCD) is a bacterial product that is widely used as a food ingredient. In the EU, αCD is regulated

Continue reading

September 9, 2022 Food / Non-pharma applications

The effect of alpha-cyclodextrin on post-prandial glucose excursions, a systematic meta analysis

Alpha-cyclodextrin (αCD) is a bacterial product that is widely used as a food ingredient. In the EU, αCD is regulated

Continue reading

August 3, 2022 CD as API / Pharma applications

HPaCD against Alzheimer Disease

HP-beta-cyclodextrin (HPbCD) is currently in clinical trials against Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease (AD) and these trials

Continue reading

November 22, 2021 Uncategorized

Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation

A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid

Continue reading

Recent Posts

  • Pharmacokinetic studies of hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex and ameliorated colitis in mice
  • A review on Sulfobutylether-β-cyclodextrin for drug delivery applications
  • Green materials with promising applications: Cyclodextrins-based deep eutectic supramolecular polymers
  • Antifungal pentachloronitrobenzene/hydroxypropyl-beta-cyclodextrin inclusion complex nanofibers by electrospinning with no polymer
  • Special issue of EuroCD2023 is open for submission

Tags

alpha-CD Alzheimer disease Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (15)
  • Analysis (37)
  • CD as API (214)
  • CD derivatives (269)
  • Cosmetics and toilettry (22)
  • Diagnosis (1)
  • Drug delivery (460)
  • E-ducation (56)
  • Environmental (80)
  • Events (163)
  • Food (128)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (19)
  • Non-pharma applications (228)
  • Other industrial use (69)
  • Pharma applications (729)
  • Supramolecular systems (27)
  • Uncategorized (47)

Top Posts

  • Pharmacokinetic studies of hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex and ameliorated colitis in mice
  • Lanosterol eye drops for cataract treatment
  • A review on Sulfobutylether-β-cyclodextrin for drug delivery applications
  • Special issue of EuroCD2023 is open for submission
  • Antifungal pentachloronitrobenzene/hydroxypropyl-beta-cyclodextrin inclusion complex nanofibers by electrospinning with no polymer
  • Green materials with promising applications: Cyclodextrins-based deep eutectic supramolecular polymers
  • 7th European Cyclodextrin Conference
  • International Symposium of Drug Delivery Systems (SDDS-2022)
  • Breathtaking anatomical view of a mammalian organism enabled by DIMEB
  • Recent books on cyclodextrins

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 552 other subscribers
 

Loading Comments...